Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 12.96
-0.15 (-1.14%)
Aug 4, 2026, 3:00 PM CST
Shinva Medical Instrument Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 489.94 | 526.34 | 691.61 | 654 | 500.07 | 556.49 |
Depreciation & Amortization | 233.46 | 233.46 | 210.24 | 213.16 | 197.34 | 200.91 |
Other Amortization | 41.49 | 41.49 | 42.55 | 45.12 | 43.78 | 52.84 |
Loss (Gain) From Sale of Assets | 0.99 | 0.99 | -0.6 | -3.75 | -2.51 | -3.53 |
Asset Writedown & Restructuring Costs | 1.81 | 1.81 | 17.33 | 12.87 | 2.03 | 4.51 |
Loss (Gain) From Sale of Investments | -39.1 | -39.1 | -70.82 | -93.65 | 7.48 | -172.94 |
Provision & Write-off of Bad Debts | 34.38 | 34.38 | 69.11 | 116.98 | 64.33 | 35.09 |
Other Operating Activities | 400.42 | 132.73 | 111.26 | 67.35 | 84.52 | 103.56 |
Change in Accounts Receivable | 16.37 | 16.37 | -615.58 | 6.82 | -329.1 | -145.01 |
Change in Inventory | 398.24 | 398.24 | 190.85 | -540.03 | -726.54 | 18.01 |
Change in Accounts Payable | -639.18 | -639.18 | -187.55 | 563.58 | 600.94 | 703.35 |
Operating Cash Flow | 931.92 | 700.64 | 450.73 | 1,030 | 388.05 | 1,403 |
Operating Cash Flow Growth | 86.01% | 55.44% | -56.24% | 165.46% | -72.33% | 27.72% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -229.06 | -381.55 | -420.88 | -535.77 | -247.58 | -274.36 |
Sale of Property, Plant & Equipment | 0.68 | 1.04 | 0.24 | 2.59 | 0.82 | 18.69 |
Cash Acquisitions | - | - | - | - | 0.67 | - |
Divestitures | 103.56 | 103.56 | - | 1.24 | - | 162.48 |
Investment in Securities | 22.43 | 4.76 | 43.31 | -4.67 | -40.5 | 205.09 |
Other Investing Activities | -618.75 | 89.34 | 58.64 | 16.71 | 5.36 | 10.31 |
Investing Cash Flow | -721.14 | -182.85 | -318.71 | -519.9 | -281.22 | 163.89 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.3 | 0.5 | 8.64 | - | - |
Long-Term Debt Issued | - | 1,217 | 1,024 | 1,145 | 1,321 | 1,071 |
Total Debt Issued | 1,064 | 1,218 | 1,024 | 1,153 | 1,321 | 1,071 |
Short-Term Debt Repaid | - | - | -8.64 | -2.73 | - | - |
Long-Term Debt Repaid | - | -1,185 | -1,081 | -1,232 | -1,214 | -2,346 |
Total Debt Repaid | -1,094 | -1,185 | -1,089 | -1,235 | -1,214 | -2,346 |
Net Debt Issued (Repaid) | -29.09 | 32.88 | -64.78 | -81.42 | 106.99 | -1,275 |
Issuance of Common Stock | - | - | - | 1,276 | 62.46 | - |
Repurchase of Common Stock | -0.25 | -0.25 | -0.08 | - | - | - |
Common Dividends Paid | -341.1 | -342.62 | -329.03 | -103.8 | -96.95 | -128.68 |
Other Financing Activities | -13.43 | -10.32 | -13.24 | -25.23 | -44.68 | -4.12 |
Financing Cash Flow | -383.88 | -320.32 | -407.13 | 1,066 | 27.81 | -1,407 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -3.55 | -0.37 | 4.03 | 6.95 | 1.4 | 0.24 |
Net Cash Flow | -176.64 | 197.09 | -271.07 | 1,583 | 136.04 | 159.31 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 702.87 | 319.09 | 29.85 | 494.34 | 140.47 | 1,128 |
Free Cash Flow Growth | - | 969.00% | -93.96% | 251.91% | -87.55% | 24.42% |
Free Cash Flow Margin | 7.26% | 3.28% | 0.30% | 4.94% | 1.51% | 11.90% |
Free Cash Flow Per Share | 1.15 | 0.53 | 0.05 | 0.82 | 0.27 | 2.14 |
Levered Free Cash Flow | 588.24 | 150.49 | -330.24 | 311.47 | 115.25 | 948.4 |
Unlevered Free Cash Flow | 613.35 | 176.37 | -302.25 | 340.89 | 150.83 | 996.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 448.19 | 405.83 | 434.79 | 419.57 | 486.1 | 546.32 |
Change in Working Capital | -231.46 | -231.46 | -619.94 | 18.05 | -508.67 | 625.29 |